1. Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence

   • Stephanie A. Navarro Silvera
   • Thomas E. Rohan

   Review 12 September 2007 Pages: 397 - 409

2. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)

   • Ander Urruticoechea
   • Monica Arnedos
   • Ian E. Smith

   Review 13 September 2007 Pages: 411 - 416

3. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

   • Dmitry A. Turbin
   • Samuel Leung
   • David G. Huntsman

   Preclinical Study 03 October 2007 Pages: 417 - 426

   

4. The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome

   • Andrew R. Green
   • Claire Burney
   • Eleni Stylianou

   Preclinical Study 28 September 2007 Pages: 427 - 437

   

5. Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria

   • Lorenza Putignani
   • Salvatore Raffa
   • Paola Grammatico

   Preclinical Study 26 September 2007 Pages: 439 - 452

   

6. Characterization of the role of CD8⁺T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers

   • Ankit Bharat
   • Nicholas Benshoff
   • T. Mohanakumar

   Preclinical Study 15 September 2007 Pages: 453 - 463

   

7. Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer

   • Yutaka Yamamoto
   • Mutsuko Ibusuki
   • Hirotaka Iwase

   Preclinical Study 06 September 2007 Pages: 465 - 475

   

8. Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables

   • Woo Chul Noh
   • Yang Hee Kim
   • Nam-Sun Paik

   Preclinical Study 06 September 2007 Pages: 477 - 483

   

9. Favourable long-term results after surgical removal of lung metastases of breast cancer

   • Masataka Yoshimoto
   • Keiichiro Tada
   • Ken Nakagawa

   Preclinical study 27 September 2007 Pages: 485 - 491

   

10. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells

    • Jennifer L. Gilmore
    • Jeffrey A. Scott
    • John Foley

    Preclinical Study 20 September 2007 Pages: 493 - 505

    

11. Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines

    • Oliver Treeck
    • Ingolf Juhasz-Boess
    • Olaf Ortmann

    Preclinical Study 18 September 2007 Pages: 507 - 520

    

12. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue

    • Vanesa Martinez
    • Susan Kennedy
    • Lorraine O’Driscoll

    Epidemiology 27 September 2007 Pages: 521 - 530

    

13. Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival

    • Masakazu Toi
    • Seigo Nakamura
    • for Japan Breast Cancer Research Group (JBCRG)

    Clinical Trial 19 September 2007 Pages: 531 - 539

    

14. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors

    • Hakan Harputluoglu
    • Omer Dizdar
    • Kadri Altundag

    Letter to the editor 13 September 2007 Pages: 541 - 541

15. Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population

    • Patricio González-Hormazábal
    • Víctor G. Castro
    • Lilian Jara

    Led to the Editor 18 September 2007 Pages: 543 - 545